NCT04499157

Effect of MEMOPTIC on Visual Field of Patients Followed for a Chronic Open-angle Glaucoma

TERMINATEDNAINTERVENTIONAL

Trial Details

Start: 2020-09-21Est. Completion: 2024-01-18

Enrollment target: 15 participants

Locations

POAGMIGS

Primary open-angle glaucoma (POAG) is a chronic eye disease in which the only validated treatment is to lower intraocula…

Amiens, FranceEst. completion Jun 2026

Primary Open Angle Glaucoma

Glaucoma is the second most common cause of blindness in the world, second only to cataracts. This study will assess how…

Glendale, United StatesEst. completion Nov 2028

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.